Oxford Nanopore Technologies plc (ONTTF)
USD 1.61
(-1.08%)
USD 1.61
(-1.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -178.88 Million GBP | 44.56% |
| 2022 | -322.68 Million GBP | 30.31% |
| 2021 | -463.03 Million GBP | -709.07% |
| 2020 | -57.23 Million GBP | -1055.6% |
| 2019 | 5.98 Million GBP | 123.19% |
| 2018 | -25.82 Million GBP | 46.54% |
| 2017 | -48.29 Million GBP | 24.62% |
| 2016 | -64.07 Million GBP | -21.81% |
| 2015 | -52.6 Million GBP | -111.55% |
| 2014 | -24.86 Million GBP | 11.57% |
| 2013 | -28.11 Million GBP | -28.3% |
| 2012 | -21.91 Million GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -115.31 Million GBP | 0.0% |
| 2023 Q4 | -178.88 Million GBP | 2.36% |
| 2023 FY | -178.88 Million GBP | 44.56% |
| 2023 Q1 | -316.91 Million GBP | 1.79% |
| 2023 Q2 | -302.18 Million GBP | 4.65% |
| 2023 Q3 | -183.2 Million GBP | 39.37% |
| 2022 Q4 | -322.68 Million GBP | 1.24% |
| 2022 FY | -322.68 Million GBP | 30.31% |
| 2022 Q3 | -326.73 Million GBP | 27.02% |
| 2022 Q2 | -447.69 Million GBP | 0.93% |
| 2022 Q1 | -451.91 Million GBP | 2.4% |
| 2021 Q4 | -463.03 Million GBP | 0.56% |
| 2021 FY | -463.03 Million GBP | -709.07% |
| 2021 Q1 | -98.18 Million GBP | -71.57% |
| 2021 Q2 | -96.4 Million GBP | 1.82% |
| 2021 Q3 | -465.64 Million GBP | -383.02% |
| 2020 Q4 | -57.23 Million GBP | 3.44% |
| 2020 FY | -57.23 Million GBP | -1055.6% |
| 2020 Q3 | -59.27 Million GBP | 0.0% |
| 2020 Q1 | 13.09 Million GBP | 0.0% |
| 2019 FY | 5.98 Million GBP | 123.19% |
| 2018 FY | -25.82 Million GBP | 46.54% |
| 2017 FY | -48.29 Million GBP | 24.62% |
| 2016 FY | -64.07 Million GBP | -21.81% |
| 2015 FY | -52.6 Million GBP | -111.55% |
| 2014 FY | -24.86 Million GBP | 11.57% |
| 2013 FY | -28.11 Million GBP | -28.3% |
| 2012 FY | -21.91 Million GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 42.79 Million USD | 518.015% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 3266.949% |
| CSL Limited | 10.52 Billion USD | 101.699% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -2737.343% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 28262.83% |
| BioStem Technologies, Inc. | 4.47 Million USD | 4100.013% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 982.23% |
| Qrons Inc. | 351.42 Thousand USD | 51001.325% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -71561.325% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 511.846% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 1496.789% |
| Skye Bioscience, Inc. | -5.72 Million USD | -3026.531% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -876423.912% |
| Rebus Holdings, Inc. | 305 Thousand USD | 58749.508% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 900492.611% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -13654938.168% |
| Genscript Biotech Corporation | -1.06 Billion USD | 83.146% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 28842.183% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 1234.816% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 4443.855% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 44614.482% |
| SQZ Biotechnologies Company | -36.23 Million USD | -393.628% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 8077.806% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 19392.893% |
| Mesoblast Limited | 55.85 Million USD | 420.241% |
| Marizyme, Inc. | 18.56 Million USD | 1063.33% |
| Genus plc | 190.6 Million USD | 193.852% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 8100.646% |
| Pharming Group N.V. | 109.8 Million USD | 262.909% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 20894.289% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 14836.203% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 26406.029% |
| ContraFect Corporation | -6.02 Million USD | -2868.487% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 132959.721% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 15581.782% |
| IMV Inc. | 7.67 Million USD | 2432.058% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 3351.261% |
| MultiCell Technologies, Inc. | 90.04 USD | 198668469.614% |
| ONE Bio Corp. | 9.04 Million USD | 2078.764% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -24271.439% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 1481.747% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 13176.374% |
| Q BioMed Inc. | 4.06 Million USD | 4505.927% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 685.459% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 17851.132% |
| Biomind Labs Inc. | 711.4 Thousand USD | 25244.855% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 395.448% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 9046.77% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 49829.226% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 128051.275% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 8223.64% |
| GB Sciences, Inc. | 1.74 Million USD | 10337.473% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -97230.076% |
| HST Global, Inc. | 96.79 Thousand USD | 184907.786% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 86844.061% |
| Halberd Corporation | 144.72 Thousand USD | 123704.038% |
| Enzolytics Inc. | 981.65 Thousand USD | 18322.371% |
| Agentix Corp. | 37.63 Thousand USD | 475455.425% |
| Resverlogix Corp. | 6.45 Million USD | 2872.919% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -26476.129% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 91.183% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | -280.501% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 2629.794% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 6704.15% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -1923.561% |
| AVAX Technologies, Inc. | -5.9 Million USD | -2930.234% |
| Zenith Capital Corp. | 10.06 Thousand USD | 1777534.42% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 89347.725% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 7597.001% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 108836.3% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -976431.281% |
| Kadimastem Ltd | -253.1 Thousand USD | -70575.459% |
| Helix BioMedix, Inc. | -2.57 Million USD | -6860.264% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 88983.202% |
| LadRx Corporation | -2.03 Million USD | -8683.88% |
| Cell Source, Inc. | 9.23 Million USD | 2037.625% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 28262.83% |
| NovAccess Global Inc. | 2.17 Million USD | 8311.332% |
| Affymax, Inc. | -5.59 Million USD | -3096.016% |
| Itoco Inc. | 228.3 Thousand USD | 78451.766% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 131640.786% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 3708.654% |
| Mobile Lads Corp. | 484.23 Thousand USD | 37041.177% |
| CytoDyn Inc. | 20.26 Million USD | 982.84% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -27647658.887% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -1929921.989% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 2421.32% |
| SYBLEU INC | 473.71 Thousand USD | 37861.392% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 4113.465% |
| International Stem Cell Corporation | 2.59 Million USD | 7006.602% |
| Bioxytran, Inc. | 1.89 Million USD | 9520.174% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 286708.559% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 8302.164% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 5309.115% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 2191.442% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 23252.91% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -14210.48% |
| Neutra Corp. | 52.18 Thousand USD | 342869.272% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -7086.862% |
| PureTech Health plc | -167.19 Million USD | -6.988% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -72940.08% |
| IXICO plc | -4.44 Million USD | -3924.693% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 1453.211% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 426.122% |
| CSL Limited | 10.52 Billion USD | 101.699% |
| Cellectis S.A. | -43.81 Million USD | -308.228% |